149 related articles for article (PubMed ID: 28423573)
1. Involvement of AF1q/MLLT11 in the progression of ovarian cancer.
Tiberio P; Lozneanu L; Angeloni V; Cavadini E; Pinciroli P; Callari M; Carcangiu ML; Lorusso D; Raspagliesi F; Pala V; Daidone MG; Appierto V
Oncotarget; 2017 Apr; 8(14):23246-23264. PubMed ID: 28423573
[TBL] [Abstract][Full Text] [Related]
2. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.
Park J; Kim S; Joh J; Remick SC; Miller DM; Yan J; Kanaan Z; Chao JH; Krem MM; Basu SK; Hagiwara S; Kenner L; Moriggl R; Bunting KD; Tse W
Oncotarget; 2016 Jul; 7(28):43960-43973. PubMed ID: 27259262
[TBL] [Abstract][Full Text] [Related]
3. AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.
Park J; Schlederer M; Schreiber M; Ice R; Merkel O; Bilban M; Hofbauer S; Kim S; Addison J; Zou J; Ji C; Bunting ST; Wang Z; Shoham M; Huang G; Bago-Horvath Z; Gibson LF; Rojanasakul Y; Remick S; Ivanov A; Pugacheva E; Bunting KD; Moriggl R; Kenner L; Tse W
Oncotarget; 2015 Aug; 6(24):20697-710. PubMed ID: 26079538
[TBL] [Abstract][Full Text] [Related]
4. AF1q Mediates Tumor Progression in Colorectal Cancer by Regulating AKT Signaling.
Hu J; Li G; Liu L; Wang Y; Li X; Gong J
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475127
[TBL] [Abstract][Full Text] [Related]
5. AF1q: a novel mediator of basal and 4-HPR-induced apoptosis in ovarian cancer cells.
Tiberio P; Cavadini E; Callari M; Daidone MG; Appierto V
PLoS One; 2012; 7(6):e39968. PubMed ID: 22761939
[TBL] [Abstract][Full Text] [Related]
6. Identification of the functional role of AF1Q in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2008 Sep; 111(1):65-78. PubMed ID: 17929166
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
Ping H; Guo L; Xi J; Wang D
Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
[TBL] [Abstract][Full Text] [Related]
10. MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML.
Xiong Y; Li Z; Ji M; Tan AC; Bemis J; Tse JV; Huang G; Park J; Ji C; Chen J; Bemis LT; Bunting KD; Tse W
Br J Haematol; 2011 Jun; 153(6):753-7. PubMed ID: 21496004
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.
Li DQ; Hou YF; Wu J; Chen Y; Lu JS; Di GH; Ou ZL; Shen ZZ; Ding J; Shao ZM
Eur J Cancer; 2006 Dec; 42(18):3274-86. PubMed ID: 16979889
[TBL] [Abstract][Full Text] [Related]
12. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
13. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer.
Gruber ES; Oberhuber G; Birner P; Schlederer M; Kenn M; Schreiner W; Jomrich G; Schoppmann SF; Gnant M; Tse W; Kenner L
Cells; 2019 Oct; 8(11):. PubMed ID: 31671695
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
15. Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.
Basu M; Bhattacharya R; Ray U; Mukhopadhyay S; Chatterjee U; Roy SS
Mol Cancer; 2015 Aug; 14():162. PubMed ID: 26298390
[TBL] [Abstract][Full Text] [Related]
16. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
17. Activation of Wnt signaling pathway by AF1q enriches stem-like population and enhance mammosphere formation of breast cells.
Tse CO; Kim S; Park J
Biochem Biophys Res Commun; 2017 Mar; 484(4):884-889. PubMed ID: 28188793
[TBL] [Abstract][Full Text] [Related]
18. Biological role and prognostic significance of NAC1 in ovarian cancer.
Nakayama K; Rahman MT; Rahman M; Yeasmin S; Ishikawa M; Katagiri A; Iida K; Nakayama N; Miyazaki K
Gynecol Oncol; 2010 Dec; 119(3):469-78. PubMed ID: 20869761
[TBL] [Abstract][Full Text] [Related]
19. AF1q/MLLT11 regulates the emergence of human prothymocytes through cooperative interaction with the Notch signaling pathway.
Parcelier A; Maharzi N; Delord M; Robledo-Sarmiento M; Nelson E; Belakhdar-Mekid H; Pla M; Kuranda K; Parietti V; Goodhardt M; Legrand N; Bernstein ID; Gluckman JC; Sigaux F; Canque B
Blood; 2011 Aug; 118(7):1784-96. PubMed ID: 21715312
[TBL] [Abstract][Full Text] [Related]
20. The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells.
Pakuła M; Mikuła-Pietrasik J; Witucka A; Kostka-Jeziorny K; Uruski P; Moszyński R; Naumowicz E; Sajdak S; Tykarski A; Książek K
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
